Socorro Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.59M Hold
315,112
3.41% 11
2026
Q1
$8.85M Sell
315,112
-66,114
-17% -$1.76M 4% 6
2025
Q4
$9.49M Sell
381,226
-59,490
-13% -$1.5M 3.68% 8
2025
Q3
$11.2M Sell
440,716
-13,304
-3% -$328K 4.05% 3
2025
Q2
$11M Buy
454,020
+23,912
+6% +$558K 3.67% 9
2025
Q1
$10.9M Buy
430,108
+29,845
+7% +$781K 3.76% 8
2024
Q4
$10.6M Buy
400,263
+133,312
+50% +$3.62M 4.15% 5
2024
Q3
$7.73M Buy
266,951
+40,545
+18% +$1.18M 2.93% 24
2024
Q2
$6.33M Hold
226,406
2.47% 28
2024
Q1
$6.28M Buy
+226,406
New +$6.28M 2.4% 29

Other funds holding PFE

Socorro Asset Management's PFE Position: Q2 2026 in Review

Socorro Asset Management held its Pfizer (PFE) position steady in Q2 2026 at 315,112 shares worth $7.59M. The position accounts for 3.41% of the portfolio, ranked #11.

Socorro Asset Management first reported a position in PFE in Q1 2024 and has held it in 10 quarters since. The position peaked at $11.2M in Q3 2025. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Socorro Asset Management held 315,112 shares of Pfizer worth $7.59M as of Q2 2026.
  • Socorro Asset Management left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 3.41% of Socorro Asset Management's portfolio in Q2 2026, its #11 holding.
  • Socorro Asset Management first reported a position in Pfizer in Q1 2024 and has held it in 10 quarters since.
  • Socorro Asset Management's Pfizer position peaked at $11.2M in Q3 2025.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Socorro Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.